1. Agid Y, Bonnet A-M, Signoret J-L, Lhermitte R (1979) Clinical, pharmacological and biochemical approach of ?onset and end-of-dose: dyskinesias. In: Poirier LJ, Sourkes TL, Bedard PJ (eds) Advances in neurology, vol 24. Raven Press, New York, pp. 401?410
2. Barbeau A (1962) The pathogenesis of Parkinson's disease: a new hypothesis. Can Med Assoc J 87:802?807
3. Barbeau A (1980) High-level levodopa therapy in severely akinetic patients: twelve years later. In: Rinne UK, Klinger M, Stamm G (eds) Parkinson's disease ? current progress, problems and management. North-Holland Biomedical Press, Amsterdam, pp 229?239
4. Contemporary neurological series;A Barbeau,1971
5. Bartholini G, Stadler H (1976) Neurotransmitter interaction in the basal ganglia: relation to extrapyramidal disorders. In: Birkmayer W, Hornykiewicz O (eds) Advances in parkinsonism. Editions Roche, Basle, pp 115?123